Physician profile
Jonathan A Lawrence
NPI 1972809382
$448.59
in general payments reported to CMS, 2019-2025
10 companies · $35.45 in 2025
The $35.45 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.80 · 2021: $110 · 2022: $30.00 · 2023: $147 · 2024: $91.81 · 2025: $35.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $99.85 | 2021-2022 | |
| Lilly USA, LLC | $87.28 | 2020-2024 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $66.02 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $49.49 | 2023 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.17 | 2021-2023 | Jardiance |
| Exact Sciences Corporation | $35.75 | 2024-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $27.18 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.18 | 2021 | |
| Scpharmaceuticals INC. | $14.47 | 2025 | |
| Pfizer INC. | $13.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.